Search images on Google      Product Monograph

Active Ingredients:

• lenacapavir (lenacapavir sodium), 309 MG/ML

DIN: 02532476

Dosage Form(s): SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: SINGLE-DOSE VIALS

Schedule: Prescription

Company: GILEAD SCIENCES CANADA INC

ATC:

• J05 - ANTIVIRALS FOR SYSTEMIC USE (ATC, WHO, Wiki)
• J05A - DIRECT ACTING ANTIVIRALS (ATC, WHO)
• J05AX - Other antivirals (ATC, WHO)
• J05AX31 - LENACAPAVIR (WHO)

 

External Links for Sunlenca:

Search on Google

• Sunlenca side effects
• Sunlenca dosage
• lenacapavir side effects
• lenacapavir dosage